Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/28/2008US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines
10/28/2008US7442378 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
10/28/2008US7442377 Protective antigen of epstein barr virus
10/28/2008US7442375 Compositions of beta-defensin inducing agents
10/28/2008US7442374 Composition for increasing the survival to slaughter rate of piglets
10/28/2008US7442370 Polymer conjugates of mutated neublastin
10/28/2008CA2433765C Use of botulinum toxin for treatment of articular pathologies
10/28/2008CA2391808C Method for treatment of symptoms of central nervous system disorders
10/28/2008CA2225924C Recombinant mistletoe lectin
10/28/2008CA2167321C Reagents and methods for the detection and quantification of testosterone in fluid samples
10/23/2008WO2008128251A1 Humanized viral vectors and methods of use thereof
10/23/2008WO2008128065A2 Tuberculosis vaccine and method of using same
10/23/2008WO2008127975A2 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008WO2008127840A2 Flavivirus ns5a proteins for the treatment of hiv
10/23/2008WO2008127757A2 An iron composition based water filtration system for the removal of chemical species containing arsenic and other metal cations and anions
10/23/2008WO2008127735A1 Il3ralpha antibody conjugates and uses thereof
10/23/2008WO2008127710A2 Methods for treating cancer resistant to erbb therapeutics
10/23/2008WO2008127656A1 Targeting abcb5 for cancer therapy
10/23/2008WO2008127655A1 Anti-alpha 6 beta 4 integrin antibodies and uses therof
10/23/2008WO2008127651A1 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/23/2008WO2008127596A1 Vaccine
10/23/2008WO2008127450A2 Linear expression cassette vaccines
10/23/2008WO2008127419A2 Compositions and methods to increase the effect of a neurotoxin treatment
10/23/2008WO2008127391A2 Antigen-antibody complexes as hiv-1 vaccines
10/23/2008WO2008127352A2 Knockout mice for pr01105, pro1279 or pro1783 coding genes
10/23/2008WO2008127347A1 Pro115 antibody compositions and methods of use
10/23/2008WO2008127307A2 Induction of an immune response against dengue virus using prime-boost approach
10/23/2008WO2008127298A2 Staphylococcal enterotoxin b peptide compositions and methods of use
10/23/2008WO2008127290A2 Alginate and alginate lyase compositions and methods of use
10/23/2008WO2008127179A1 Fusion protein vaccine
10/23/2008WO2008127105A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof
10/23/2008WO2008127102A1 S. pnuemoniae transcytosis protein
10/23/2008WO2008127099A1 Prevention of staphylococcus biofilm formation
10/23/2008WO2008127094A2 New virulence factors of streptococcus pnuemoniae
10/23/2008WO2008126847A1 Prophylactic or therapeutic agent for cancer
10/23/2008WO2008126413A1 Tem8 peptides and vaccines comprising the same
10/23/2008WO2008126065A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/23/2008WO2008125985A2 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
10/23/2008WO2008125366A2 Treatment of autoimmune diseases
10/23/2008WO2008125360A1 Method for purification of viral proteins
10/23/2008WO2008125119A1 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a
10/23/2008WO2008125117A1 Cell culture system of a hepatitis c genotype 3a and 2a chimera
10/23/2008WO2008124870A1 Delivery of flu antibodies to surfaces in contact with air
10/23/2008WO2008105902A3 Novel nanoparticles for biofilm targeting
10/23/2008WO2008097267A3 Vaccines against vesicular stomatitis
10/23/2008WO2008086386A3 Adenoviral vector-based malaria vaccines
10/23/2008WO2008086335A3 Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
10/23/2008WO2008076981A3 Inhibitors of ll-37- mediated immune reactivity to self nucleic acids
10/23/2008WO2008073642A3 Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
10/23/2008WO2008070363A3 Intrabodies
10/23/2008WO2008070284A3 Amyloid beta peptides and methods of uses thereof
10/23/2008WO2008060783A3 Ccr2 antagonists for treatment of fibrosis
10/23/2008WO2008060705A3 Anti-dll4 antibodies and methods using same
10/23/2008WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)
10/23/2008WO2008049643A3 Gd2 peptide mimotopes for anticancer vaccination
10/23/2008WO2008049053A3 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
10/23/2008WO2008048984A3 Methods and compositions for preparing a universal influenza vaccine
10/23/2008WO2008047023A3 Immunisation method against the 4 dengue serotypes
10/23/2008WO2008031020A3 Arginine wash in protein purification using affinity chromatography
10/23/2008WO2008028117A3 Glp-2 mimetibodies, polypeptides, compositions, methods and uses
10/23/2008WO2008025020A3 Cd30 binding agents and uses thereof
10/23/2008WO2008020330A9 Immunogens from uropathogenic escherichia coli
10/23/2008WO2008019291A3 Anti-alix antibodies and hybridomas
10/23/2008WO2008008986A3 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
10/23/2008WO2007146309A3 Methods for manipulating stem cells
10/23/2008WO2007146188A3 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
10/23/2008WO2007134274A3 Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy
10/23/2008WO2007127803A3 Administration of growth factors for the treatment of cns disorders
10/23/2008WO2007126787A3 Reagents and methods for cancer treatment and prevention
10/23/2008WO2007109254A3 Stabilized polypeptide compositions
10/23/2008WO2007108829A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
10/23/2008WO2007106415A3 Triggered self-assembly conjugates and nanosystems
10/23/2008WO2007095746A9 Cancerous disease modifying antibodies
10/23/2008WO2007065037A3 Antibodies against mmp-13 (collagenase-3) and uses thereof
10/23/2008WO2007048127A3 Fc labeling for immunostaining and immunotargeting
10/23/2008WO2006135799A3 Detection of hookworm coproantigens
10/23/2008WO2006076285A3 Adhesin as immunogen against escherichia coli
10/23/2008WO2005065382A8 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
10/23/2008US20080262444 Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262204 A purified affinity-matured antibody or a portion thereof having binding specificity for 83 kDa protective antigen (PA83) of Bacillus anthracis; confers protection to a host against a tripartite toxin of Bacillus anthracis; cloned from an anti-Bacillus anthracis PA83 hybridoma
10/23/2008US20080262197 Methods and materials for treating inflammatory conditions
10/23/2008US20080261919 Camptothecin-analog with a novel, "flipped" lactone-stable, E-ring and methods for making and using same
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261289 Compositions comprising viruses and methods for concentrating virus preparations
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260851 Comprised of acrylic acid or acrylamide; well dispersed in water due to their size, and can contain, encapsulate, incorporate, extract and release molecules, such as active molecules, agents, or ingredients, including bioactive molecules
10/23/2008US20080260847 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent
10/23/2008US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent
10/23/2008US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery
10/23/2008US20080260825 Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
10/23/2008US20080260822 SYNTHESIS OF HUMAN SECRETORY IgA AND IgM AND THE FORMATION OF A MEDICAMENT THEREFROM
10/23/2008US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260800 Potentiation with such as small intestinal submucosal (SIS) tissue; harnessing inflammatory provoking activity; prostate glands
10/23/2008US20080260798 Utilizing biocompatible, three dimensional cell growth promoting device containing alternating layers of A and S strips; providing preferential cellular attachment to active A strips rather than spacer S strips
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 1823